{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Las Vegas",
      "state": "NV",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73537",
      "recalling_firm": "Meditech Laboratories, Inc",
      "address_1": "3200 Polaris Ave Ste 27",
      "address_2": "N/A",
      "postal_code": "89102-8379",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0802-2016",
      "product_description": "Formula 2 (Papaverine 9 mg, Phentolamine 1 mg, Atropine 0.1 mg, PGE 10 mcg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV  89102.",
      "product_quantity": "1320 vials - all formulas",
      "reason_for_recall": "Superpotent Drug: one ingredient was found to be above assay specification.",
      "recall_initiation_date": "20160314",
      "center_classification_date": "20160401",
      "termination_date": "20160607",
      "report_date": "20160413",
      "code_info": "Lot #: 110115-2, Exp 01/01/16",
      "more_code_info": ""
    }
  ]
}